Fractyl Health, Inc. GUTS 深 沪
等待开盘 01-30 09:30:00 美东时间
0.5849
-1.245
-68.04%
华盛通- 最 高0.68
- 今 开0.6719
- 成交量 8969.84万股
- 最 低 0.563
- 昨 收 1.83
- 总市值 8013.13万
- 52周最高 3.03
- 市盈率 静 --
- 换手率 65.47%
- 52周最低 0.563
- 委 比 98.26%
- 总股本 1.37亿
- 历史最高 14.50
- 量 比 16.06
- 振 幅 6.39%
- 历史最低 0.563
- 每 手 1
- 风险率 0.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fractyl Health Announces 6-Month Randomized Results From Ongoing REMAIN-1 Midpoint Cohort, Blinded, Sham-Controlled Study Evaluating Revita For Weight Maintenance Following GLP-1 Drug Discontinuation
Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months compared with sham, with continued excellent safety and tolerabilityPatients with
01-29 20:04
Fractyl Health Outlines Its Strategic Outlook For 2026, Highlighting Anticipated Clinical And Regulatory Milestones Across Its Revita And Rejuva Programs, Cash Balance Of $85.6M Is Expected To Provide Cash Runway Through Early 2027
RevitaIn 2026, the Company plans to advance Revita through a series of important clinical and regulatory milestones, building on continued progress across the REVEAL-1, REMAIN-1 Midpoint, and REMAIN-1 Pivotal Cohorts as
01-05 20:22
Fractyl Health Calls All 17,063,073 Warrants For Cancellation For Cash: Exercise At $1.05, If Fully Exercised Could Raise ~$17.9M
Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company" or "Fractyl"), a metabolic therapeutics company focused on pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes ("T2D"), today
2025-12-16 07:35
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers GT Biopharma (NASDAQ:GTBP) shares moved upwards by 6.6% to $0.65 durin...
2025-12-06 05:05
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
美股牛股 | 绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%
绩优股MongoDB大涨超22%，公司上调全年营收预测；Eventbrite飙升78.6%，拟被5亿美元收购并私有化>>
2025-12-03 15:05
Fractyl Health Announces 6-Month Results From Open-Label REVEAL-1 Cohort; Upcoming Randomized 6-Month REMAIN-1 Midpoint Cohort Data Expected In January 2026
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment1.5% mean weight change observed with Revita (n=17);
2025-12-02 20:07
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
2025-11-24 11:23
Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $8
Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $6 to $8.
2025-11-22 02:30
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
